Bio-Peptide

17 products

• Lab Tested

  ACVR2B 10mg/vial 1 Vial by Bio-Peptide

  ACE-031 (ACVR2B) is a recombinant soluble fusion protein engineered to sequester myostatin, activin A, and GDF-11 before these ligands reach membrane-bound receptors on skeletal muscle fibres, experimentally studied for its capacity to remove the principal molecular constraint on muscle fibre growth and number. Each vial contains 10 mg of lyophilised powder, positioning this compound within the TGF-β superfamily inhibition axis — a mechanistic approach distinct from androgen receptor agonism or direct GH-axis stimulation. Independent third-party laboratories perform both HPLC sequence and purity verification and LAL endotoxin screening on every batch before vials are released, with batch-specific documentation available on request.

  €60.00
• Lab Tested

  BPC-157 5mg/vial 1 Vial by Bio-Peptide

  BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide extensively studied for musculoskeletal repair, giving researchers the option of localised peri-articular injection or systemic subcutaneous delivery for broader connective-tissue recovery. Each vial from Bio-Peptide supplies 5 mg of lyophilized BPC-157, a research-grade concentration well-suited to tendon, ligament, and joint rehabilitation protocols. Independent HPLC purity analysis and LAL endotoxin testing are applied to every batch, with production carried out under current Good Manufacturing Practice (cGMP) conditions.

  €34.00
• Lab Tested

  CJC-1295 5mg/vial 1 Vial by Bio-Peptide

  CJC-1295 DAC is a Drug Affinity Complex–modified GHRH analogue provided as 5 mg of lyophilized powder per vial, engineered to sustain pulsatile growth hormone stimulation by anchoring to serum albumin — stretching the effective dosing interval from daily to just one or two injections each week. Its extended plasma half-life of roughly 6–8 days positions it as the long-acting member of the CJC-1295 peptide family, distinguishing it clearly from the unmodified Modified GRF 1-29 sequence. Every production batch is subjected to independent HPLC purity analysis and LAL endotoxin quantification before a single unit is approved for release.

  €36.00
• Lab Tested

  Follistatin 344 1mg/vial 1 Vial by Bio-Peptide

  Follistatin-344 is a 344-amino-acid glycoprotein isoform that binds and neutralises myostatin (GDF-8), eliminating the principal molecular constraint on skeletal muscle fibre formation and making it one of the most studied experimental peptides for satellite-cell-driven muscle hyperplasia research. Bio-Peptide supplies this compound as a lyophilised research vial containing 1 mg of sequence-verified Follistatin-344 — a precise entry-point dose engineered for low-dose titration studies and flexible reconstitution-volume design in ActRIIB pathway investigations. Every vial is independently verified by third-party laboratories for HPLC purity and LAL endotoxin compliance before release, with synthesis conducted under cGMP-aligned process controls.

  €38.00
• Lab Tested

  GHRP-2 10mg/vial 1 Vial by Bio-Peptide

  GHRP-2 is a synthetic hexapeptide ghrelin mimetic that stimulates pituitary growth hormone release with notably lower hunger-inducing side effects compared to GHRP-6 — making it the preferred GHRP for users who want GH output without significant appetite disruption. Each vial contains 10 mg of lyophilized GHRP-2 at research-grade purity, suitable for reconstitution with bacteriostatic water for subcutaneous administration. Quality is enforced at every batch: independent HPLC sequence verification and LAL endotoxin certification are completed externally before any vial reaches dispatch.

  €32.00
• Lab Tested

  GHRP-6 & CJC-1295 MIX 10mg/vial 1 Vial by Bio-Peptide

  GHRP-6 & CJC-1295 MIX is a dual-peptide lyophilized research compound combining ghrelin-mimetic GHRP-6 (10 mg per vial) with CJC-1295, uniquely positioned among growth hormone secretagogue blends by its pronounced appetite-stimulating profile — a characteristic that separates it clinically from GHRP-2 and makes it the preferred choice for users in caloric surplus or mass-building phases. GHRP-6 binds the ghrelin receptor (GHS-R1a) with high affinity, driving pulsatile GH release while simultaneously activating hypothalamic hunger pathways — an on-target effect absent or markedly blunted with GHRP-2. Quality assurance is built into every batch: HPLC purity verification and LAL endotoxin certification are completed by an independent third-party laboratory before any vial is released.

  €32.00
• Lab Tested

  Hexarelin 10mg/vial 1 Vial by Bio-Peptide

  Hexarelin is a synthetic hexapeptide GHRP analogue — and the most potent growth-hormone-releasing peptide identified in its class — supplied here as a lyophilised powder at 10 mg per vial by Bio-Peptide. Unlike lower-potency GHRPs, Hexarelin produces the strongest acute GH pulse among its peers, which makes proactive desensitisation management an essential part of any research protocol. Quality assurance is built into every batch: independent third-party HPLC purity verification and LAL endotoxin certification are completed before any vial is released, all within a cGMP-aligned production framework.

  €34.00
• Lab Tested

  HGH Fragment 5mg/vial 1 Vial by Bio-Peptide

  HGH Fragment (176-191) is the synthetically produced C-terminal peptide spanning residues 176 to 191 of the human growth hormone sequence, supplied by Bio-Peptide as a lyophilised powder at 5 mg per vial, and designed to deliver selective lipolytic activity without engaging the anabolic or mitogenic pathways of full-length GH. Retaining only the fat-signalling region of the HGH molecule, this fragment promotes adipose tissue breakdown at a cellular level while leaving IGF-1 output and skeletal growth mechanisms entirely undisturbed. Each production batch is cleared through third-party HPLC sequence and purity analysis alongside LAL endotoxin screening before any vial is released for distribution.

  €38.00
• Lab Tested

  Des IGF 1mg/vial 1 Vial by Bio-Peptide

  Bio-Peptide Des (1-3) IGF-1 is a truncated analogue of Insulin-Like Growth Factor-1, lyophilized at 1 mg per vial, engineered to bypass IGFBP binding proteins and deliver concentrated receptor activation directly at the injected muscle site. Absent the three N-terminal amino acids found in full-length IGF-1, this variant binds the IGF-1 receptor with approximately 10-fold greater affinity in vitro, generating intense, localized anabolic signalling that makes it the preferred tool for compartmentalized hypertrophy protocols. Each vial is independently verified through HPLC sequence confirmation and LAL endotoxin screening prior to release, ensuring batch-traceable purity and injection safety.

  €36.00
• Lab Tested

  IGF-1 LR3 1mg/vial 1 Vial by Bio-Peptide

  Bio-Peptide IGF-1 LR3 delivers a long-acting, arginine-substituted insulin-like growth factor-1 analogue as 1 mg of lyophilised peptide per vial, formulated to stimulate myofiber proliferation and channel caloric substrate toward skeletal muscle rather than adipose tissue. Its resistance to IGF binding proteins extends circulating half-life to approximately 20–30 hours—roughly 60× that of native IGF-1—enabling sustained receptor engagement throughout the post-training anabolic window. Independent batch release combines HPLC sequence confirmation with a LAL endotoxin screen, and the resulting certificates are tied to unique lot identifiers for full traceability.

  €36.00
• Lab Tested

  Ipamorelin 10mg/vial 1 Vial by Bio-Peptide

  Ipamorelin is a selective pentapeptide growth hormone secretagogue that triggers pituitary GH pulses without stimulating appetite or elevating cortisol — making it the cleanest GHRP available for lean-phase research protocols. Each vial from Bio-Peptide delivers 10 mg of lyophilized Ipamorelin, precision-dosed for reconstitution with bacteriostatic water. Purity and endotoxin status are verified per batch: HPLC sequence confirmation and LAL endotoxin screening are completed by an independent laboratory before any vial is released.

  €32.00
• Lab Tested

  MT-2 10mg/vial 1 Vial by Bio-Peptide

  MT-2 (Melanotan 2) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) engineered to activate MC1R for eumelanin-driven skin darkening, MC3R/MC4R for appetite reduction, and central MC4R pathways for libido enhancement — all within a single 10 mg lyophilised vial format. Bio-Peptide formulates MT-2 as a lyophilised powder at 10 mg per vial, a quantity that accommodates both conservative sub-milligram loading schedules and reduced-frequency maintenance phases without reformulation. Each batch clears two independent laboratory gates before release: HPLC analysis locks in sequence identity and purity, while LAL endotoxin screening certifies microbiological safety to injection-grade standards.

  €36.00
• Lab Tested

  MGF 5mg/vial 1 Vial by Bio-Peptide

  Mechano Growth Factor (MGF) is a splice variant of IGF-1 that the body produces locally within mechanically stressed muscle tissue in direct response to resistance training, supplied here by Bio-Peptide as a lyophilised peptide at 5 mg per vial. Unlike systemic growth factors, MGF acts in a paracrine fashion — signalling satellite cells at the site of micro-damage to initiate the muscle repair and hypertrophy cascade. Batch release is subject to a two-stage analytical protocol: HPLC sequence verification and LAL endotoxin screening are completed by an independent contracted laboratory before any vial is labelled or shipped.

  €32.00
• Lab Tested

  MOD GRF 1-29 10mg/vial 1 Vial by Bio-Peptide

  Mod GRF 1-29 (CJC-1295 without DAC) is a stabilised 29-amino-acid Growth Hormone-Releasing Hormone analogue supplied by Bio-Peptide as a lyophilised powder at 10 mg per vial — engineered to pair with a GHRP such as Ipamorelin to drive coordinated, amplified GH pulses via simultaneous pituitary receptor activation. The 10 mg/vial fill supports uninterrupted multi-week research runs, delivering more injection sessions per vessel than any lower-concentration format in this product group. Every batch clears two mandatory external checkpoints before release: HPLC analysis confirms sequence identity and purity, and a LAL endotoxin assay certifies microbiological safety at the batch level.

  €34.00
• Lab Tested

  Peg MGF 5mg/vial 1 Vial by Bio-Peptide

  PEG-MGF (PEGylated Mechano-Growth Factor) is an extended-acting synthetic analogue of the exercise-induced IGF-1 splice variant, supplied here by Bio-Peptide as a lyophilised 5mg research peptide per vial. The PEGylation process attaches polyethylene glycol chains to the native MGF sequence, dramatically prolonging circulatory half-life from minutes to several days and broadening systemic distribution to satellite cells across multiple muscle groups simultaneously. Quality is enforced at two independent checkpoints — HPLC sequencing for purity confirmation and a LAL endotoxin assay for sterility — both externally commissioned and batch-documented before any vial is cleared for release.

  €32.00
• Lab Tested

  Sermorelin Acetate 5mg/vial 1 Vial by Bio-Peptide

  Sermorelin Acetate is a synthetic 29-amino-acid fragment of endogenous growth hormone-releasing hormone (GHRH), supplied by Bio-Peptide as a lyophilised powder at 5 mg per vial and distinguished by its long-standing role in anti-aging and longevity-focused research protocols. As the classical GHRH(1-29) analog, sermorelin stimulates pituitary somatotrophs in a pulsatile, physiologically mimetic pattern — making it the benchmark reference compound against which newer GHRH-related peptides are evaluated. Quality is assured at batch level: each vial clears HPLC sequence-and-purity verification and an independent LAL endotoxin assay before release, with documentation attached to every lot.

  €32.00
• Lab Tested

  TB-500 10mg/vial 1 Vial by Bio-Peptide

  Bio-Peptide TB-500 (Thymosin Beta-4 Fragment) is a 10 mg lyophilised research peptide engineered to support systemic tissue regeneration and whole-body joint flexibility — acting simultaneously on connective tissue, muscle fibre, and vascular networks rather than targeting a single injury site. Each vial delivers a concentrated 10 mg payload, reconstituted with bacteriostatic water for subcutaneous or intramuscular administration. Quality assurance is structured as two mandatory external checkpoints: HPLC sequence and purity confirmation, followed by LAL endotoxin testing — both completed before the batch is cleared for release.

  €36.00